Sarcoma

Aims & Scope

Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research.

It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy.

High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi’s sarcoma, are published as well as preclinical and animal studies.

This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients.

It is of interest to all those working with bone and soft tissue tumours, including medical, surgical and paediatric oncologists, radiotherapists, pathologists and research scientists.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.666

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	55

Journal Rank

Year	Value
2024	8598

Journal Citation Indicator

Year	Value
2024	89

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era

  Citation: 309

  Authors: Daniel C., Scott C., Elke R., Andrew, Sant, Alex, Constance, Lawrence R.

• The Molecular Pathogenesis of Osteosarcoma: A Review

  Citation: 250

  Authors: Matthew L., Jonathan C. M., Damian E., Crispin R., Peter F. M.

• The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS‐I Through IRS‐IV Studies as Background for the Current IRS‐V Treatment Protocols

  Citation: 238

  Authors: R. Beverly, Harold M., James R., Richard J., Sarah S., Stephen J., Moody D., Eugene S., William M.

• Using Epidemiology and Genomics to Understand Osteosarcoma Etiology

  Citation: 207

  Authors: Sharon A., Lisa

• The Genetics of Osteosarcoma

  Citation: 189

  Authors: Jeff W., Jeremy A., Maria

• “Malignant” Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies

  Citation: 161

  Authors: Jonathan S., J. Fernando, Andrew L.

• Liposarcoma: Molecular Genetics and Therapeutics

  Citation: 149

  Authors: Rachel, Sophie, David M.

• A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

  Citation: 141

  Authors: Robert G., Achim A., Sacha, Gary K., David R., Mary Louise, Michael J., Kelly, Rita, Erika, Jennifer, Israel, Lloyd J., Gerd

• Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family

  Citation: 110

  Authors: Heinrich

• The Role of RUNX2 in Osteosarcoma Oncogenesis

  Citation: 109

  Authors: J. W., M., G. S., A. J., J. A.

---